Cost effectiveness of MF59 adjuvanted influenza vaccine in France

被引：0
|
作者：
Chambers, J.
Eijgelshoven, I
Piercy, J.
Wait, S.
机构：
[1] Mapi Values, Boston, MA USA
[2] Mapi Values, Houten, Netherlands
[3] Phimap, Bollington, England
[4] SHW Hlth, London, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)69036-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A163 / A164
页数：2
相关论文
共 50 条
  • [41] Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults
    Frey, S
    Poland, G
    Percell, S
    Podda, A
    VACCINE, 2003, 21 (27-30) : 4234 - 4237
  • [42] MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
    O'Hagan, Derek T.
    EXPERT REVIEW OF VACCINES, 2007, 6 (05) : 699 - 710
  • [43] INTRANASAL VACCINATION WITH SUBUNIT INFLUENZA VACCINE COMBINED WITH THE ADJUVANTS LTK63 OR MF59
    BARCHFELD, GL
    HESSLER, AL
    HIGGINS, DA
    CATALDO, D
    TRAQUINA, P
    PIZZA, M
    DEMAGISTRIS, MT
    DOUCE, G
    DOUGAN, G
    VANNEST, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 254 - 254
  • [44] Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
    Knuf, Markus
    Leroux-Roels, Geert
    Ramke, Hans. C.
    Abarca, Katia
    Rivera, Luis
    Lattanzi, Maria
    Pedotti, Paola
    Arora, Ashwani
    Kieninger-Baum, Dorothee
    Della Cioppa, Giovanni
    VACCINE, 2015, 33 (01) : 174 - 181
  • [45] Systematic review of the efficacy, effectiveness and safety of MF59(R) adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age
    Murchu, Eamon O.
    Comber, Laura
    Jordan, Karen
    Hawkshaw, Sarah
    Marshall, Liam
    O'Neill, Michelle
    Ryan, Mairin
    Teljeur, Conor
    Carnahan, Annasara
    Jesus Perez, Jaime
    Robertson, Anna Hayman
    Johansen, Kari
    de Jonge, Jorgen
    Krause, Tyra
    Nicolay, Nathalie
    Nohynek, Hanna
    Pavlopoulou, Ioanna
    Pebody, Richard
    Penttinen, Pasi
    Soler-Soneira, Marta
    Wichmann, Ole
    Harrington, Patricia
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (03)
  • [46] Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age
    Puig-Barberà, J
    Diez-Domingo, J
    Hoyos, SP
    Varea, AB
    Vidal, DG
    VACCINE, 2004, 23 (03) : 283 - 289
  • [47] Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis
    Patel, Manish M.
    Davis, William
    Beacham, Lauren
    Spencer, Sarah
    Campbell, Angela P.
    Lafond, Kathryn
    Rolfes, Melissa
    Levine, Min Z.
    Azziz-Baumgartner, Eduardo
    Thompson, Mark G.
    Fry, Alicia M.
    VACCINE, 2020, 38 (03) : 608 - 619
  • [48] A Caprine Herpesvirus 1 Vaccine Adjuvanted with MF59™ Protects against Vaginal Infection and Interferes with the Establishment of Latency in Goats
    Marinaro, Mariarosaria
    Rezza, Giovanni
    Del Giudice, Giuseppe
    Colao, Valeriana
    Tarsitano, Elvira
    Camero, Michele
    Losurdo, Michele
    Buonavoglia, Canio
    Tempesta, Maria
    PLOS ONE, 2012, 7 (04):
  • [49] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    Gasparini, R
    Pozzi, T
    Montomoli, E
    Fragapane, E
    Senatore, F
    Minutello, M
    Podda, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (02) : 135 - 140
  • [50] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    R. Gasparini
    T. pozzi
    E. Montomoli
    E. Fragapane
    F. Senatore
    M. Minutello
    A. Podda
    European Journal of Epidemiology, 2001, 17 : 135 - 140
12345